Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer

Gram-positive bacterial infections are an important cause of morbidity and death among cancer patients, despite current therapy. In this case-control study, we evaluated the clinical outcomes and safety of telavancin in cancer patients with uncomplicated Gram-positive bloodstream infections (BSIs)....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Antimicrob Agents Chemother
Egile Nagusiak: Chaftari, Anne-Marie, Hachem, Ray, Jordan, Mary, Garoge, Kumait, Al Hamal, Zainab, El Zakhem, Aline, Viola, George M., Granwehr, Bruno, Mulanovich, Victor, Gagel, Andrew, Reitzel, Ruth, Yousif, Ammar, Jiang, Ying, Raad, Issam
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2015
Gaiak:
Clinical Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704239/
https://ncbi.nlm.nih.gov/pubmed/26482312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00617-15
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak